Nuclear medicine methods in the diagnosis and treatmentof high-risk neuroblastoma - case report

Abstract

Neuroblastoma is childhood’s most common extracranial solid tumor, with a broad spectrum of biological conduct. The high-risk disease encompasses a significant portion of childhood cancer mortality. Nuclear medicine methods, including disease risk categorization, are essential in the diagnostic process. However, nuclear medicine has its place as a segment of the multidisciplinary treatment of high-risk diseases, too. In this article, a patient diagnosed with high-risk neuroblastoma due to age and metastases is presented, with an accent on the role of nuclear medicine and a multidisciplinary approach in diagnostic and therapeutic procedures.